Login | >
You are here: Home > About Us > About Us

About Us

 

Vision and Mission Statements

Our vision and strategy are derived from the Hadassah Medical Organization’s (HMO) mission statement as follows:“…the Hadassah Medical Organization is committed to … excellence in research by which the frontiers of medicine are advanced to benefit humankind, and excellence in teaching by which future generations are assured the highest quality of care and scholarship."

We believe this vision will continue as our reality by enhancing the position of Hadassah as a center of excellence in Medical & Biomedical Research and Development, with the goal of improved healthcare for all.

Research Committee

It is the qualitative research conducted within the walls of the hospital that built Hadassah Medical Center into what we see today; and it is the continued level of outstanding research that has maintained Hadassah's standing as a leading research and teaching institution in Israel and abroad. Headed up by the Division of Research and Development, Hadassah has set itself the goal of serving as a hotbed of innovation entailing everything from basic to clinical research projects.

A Committee of 26 members, including world-renowned senior researchers and the best of the new crop of young, enthusiastic researchers, serve to guide and support the advancement of qualitative research. The Committee is required to formulate institutional research goals, ensure a course of action and ultimately achieve these goals in the coming years; all the while, building on the fabric of the Hadassah society including finding the best staff and resources.

Research Fund of the Hadassah Medical Organization

Hadassah Medical Organization (HMO) is currently conducting the entire scope of research from basic to advanced clinical trials via the newly established non-profit registered association named "Research Fund of the Hadassah Medical Organization" (RFHMO).

The association is a separate legal entity administered by the following HMO officers:
Prof. Zeev Rotstein, HMO CEO – Chairman of the Board of Directors
Prof. Eyal Mishani, Head of HMO R&D Division – Member of the Board of Directors and General Director of the Fund.
Mr. Oren Levi, HMO Senior Deputy Director General – Member of the Board of Directors.
Prof. Yoram Weiss, General Manager of HMO Ein Kerem Hospital – Member of the Board of Directors.
Mr. Yuval Adar, HMO CFO – Member of the Board of Directors.

The association handles all administrative matters relating to research & development on behalf of HMO, including human resources and financial aspects. All research contracts for grant awards, research & development collaborations and donations are signed by the RFHMO. Research & Development funding is secured by the association's bank account, managed independently by the RFHMO staff and undergoes external financial audits periodically.

All research activities continue to be conducted within HMO's facilities by HMO's principal investigators in a transparent and seamless fashion.
To ensure all resources are solely directed for research purposes, as well as secure the long term viability of research activities at HMO, Research & Development resources are managed by a separate and independent registered association.

Institutional Review Board (IRB)

The Institutional Review Board (Helsinki Committee) is an independent committee appointed by the CEO of a medical institution, whose composition, methods of appointment and Quorum are defined in the regulations. The role of the Committee is to safeguard the rights, safety and well-being of participants recruited for a clinical trial, by performing a thorough review of all aspects and approval of a clinical trial protocol and informed consent form. Also, the role of the Committee is to conduct regulatory monitoring of ongoing clinical trials, including protocol changes. The Committee performs its functions based on written operating procedures for clinical trials in humans, in accordance with the "Public Health Regulation" ("Briut-Ha'am", clinical trials, 1980 and as amended and add-on 1999), and following the general principles outlined in the Helsinki Declaration.